These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17465728)

  • 41. Single-channel pharmacology of mibefradil in human native T-type and recombinant Ca(v)3.2 calcium channels.
    Michels G; Matthes J; Handrock R; Kuchinke U; Groner F; Cribbs LL; Pereverzev A; Schneider T; Perez-Reyes E; Herzig S
    Mol Pharmacol; 2002 Mar; 61(3):682-94. PubMed ID: 11854450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kurtoxin, a gating modifier of neuronal high- and low-threshold ca channels.
    Sidach SS; Mintz IM
    J Neurosci; 2002 Mar; 22(6):2023-34. PubMed ID: 11896142
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological studies of Cav3.1 T-type calcium channels using automated patch-clamp techniques.
    Choi KH; Song C; Cheong CS; Rhim H
    Gen Physiol Biophys; 2011 Mar; 30(1):100-5. PubMed ID: 21460418
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of 1-(isoxazol-5-ylmethylaminoethyl)-4-phenyl tetrahydropyridine and piperidine derivatives as potent T-type calcium channel blockers with antinociceptive effect in a neuropathic pain model.
    Lee JH; Seo SH; Lim EJ; Cho NC; Nam G; Kang SB; Pae AN; Jeong N; Keum G
    Eur J Med Chem; 2014 Mar; 74():246-57. PubMed ID: 24480356
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Voltage gated calcium channels as targets for analgesics.
    Bourinet E; Zamponi GW
    Curr Top Med Chem; 2005; 5(6):539-46. PubMed ID: 16022676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 5beta-reduced neuroactive steroids are novel voltage-dependent blockers of T-type Ca2+ channels in rat sensory neurons in vitro and potent peripheral analgesics in vivo.
    Todorovic SM; Pathirathna S; Brimelow BC; Jagodic MM; Ko SH; Jiang X; Nilsson KR; Zorumski CF; Covey DF; Jevtovic-Todorovic V
    Mol Pharmacol; 2004 Nov; 66(5):1223-35. PubMed ID: 15280444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Scorpion toxins that block T-type Ca2+ channels in spermatogenic cells inhibit the sperm acrosome reaction.
    López-González I; Olamendi-Portugal T; De la Vega-Beltrán JL; Van der Walt J; Dyason K; Possani LD; Felix R; Darszon A
    Biochem Biophys Res Commun; 2003 Jan; 300(2):408-14. PubMed ID: 12504099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.
    Howitt L; Kuo IY; Ellis A; Chaston DJ; Shin HS; Hansen PB; Hill CE
    Cardiovasc Res; 2013 Jun; 98(3):449-57. PubMed ID: 23436820
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Block of cloned human T-type calcium channels by succinimide antiepileptic drugs.
    Gomora JC; Daud AN; Weiergräber M; Perez-Reyes E
    Mol Pharmacol; 2001 Nov; 60(5):1121-32. PubMed ID: 11641441
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs.
    Perez-Reyes E; Van Deusen AL; Vitko I
    J Pharmacol Exp Ther; 2009 Feb; 328(2):621-7. PubMed ID: 18974361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Novel T-type calcium channel blockers: dioxoquinazoline carboxamide derivatives.
    Jo MN; Seo HJ; Kim Y; Seo SH; Rhim H; Cho YS; Cha JH; Koh HY; Choo H; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(1):365-73. PubMed ID: 17035033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic ablation of CaV3.2 channels enhances the arterial myogenic response by modulating the RyR-BKCa axis.
    Harraz OF; Brett SE; Zechariah A; Romero M; Puglisi JL; Wilson SM; Welsh DG
    Arterioscler Thromb Vasc Biol; 2015 Aug; 35(8):1843-51. PubMed ID: 26069238
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nickel block of three cloned T-type calcium channels: low concentrations selectively block alpha1H.
    Lee JH; Gomora JC; Cribbs LL; Perez-Reyes E
    Biophys J; 1999 Dec; 77(6):3034-42. PubMed ID: 10585925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Ca(v)3.2 T-type Ca(2+) channel is required for pressure overload-induced cardiac hypertrophy in mice.
    Chiang CS; Huang CH; Chieng H; Chang YT; Chang D; Chen JJ; Chen YC; Chen YH; Shin HS; Campbell KP; Chen CC
    Circ Res; 2009 Feb; 104(4):522-30. PubMed ID: 19122177
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and biological evaluation of oxazole derivatives as T-type calcium channel blockers.
    Lee JE; Koh HY; Seo SH; Baek YY; Rhim H; Cho YS; Choo H; Pae AN
    Bioorg Med Chem Lett; 2010 Jul; 20(14):4219-22. PubMed ID: 20621730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Milestones to the Discovery of T-type Calcium Channel Blockers for the Treatment of Generalized Epilepsies.
    Bezençon O; Siegrist R; Heidmann B; Pozzi D; Stamm S; Remeň L; Richard S; Simons L; Gaston R; Downing D; Grisostomi C; Roch C; Kessler M; Gatfield J; Moon R; Pfeifer T; Mosbacher J; Reymond I; Ertel EA; de Kanter R; Capeleto B; Fournier E; Rey M; Moccia L; Toeroek-Schafroth M; Roscher R; Schindelholz B
    Chimia (Aarau); 2017 Oct; 71(10):722-729. PubMed ID: 29070417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential inhibition of T-type calcium channels by neuroleptics.
    Santi CM; Cayabyab FS; Sutton KG; McRory JE; Mezeyova J; Hamming KS; Parker D; Stea A; Snutch TP
    J Neurosci; 2002 Jan; 22(2):396-403. PubMed ID: 11784784
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 3D pharmacophore based virtual screening of T-type calcium channel blockers.
    Doddareddy MR; Choo H; Cho YS; Rhim H; Koh HY; Lee JH; Jeong SW; Pae AN
    Bioorg Med Chem; 2007 Jan; 15(2):1091-105. PubMed ID: 17074493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation, Antiepileptic Activity, and Cardiovascular Safety of Dihydropyrazoles as Brain-Penetrant T-Type Calcium Channel Blockers.
    Remen L; Bezençon O; Simons L; Gaston R; Downing D; Gatfield J; Roch C; Kessler M; Mosbacher J; Pfeifer T; Grisostomi C; Rey M; Ertel EA; Moon R
    J Med Chem; 2016 Sep; 59(18):8398-411. PubMed ID: 27579577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ca
    Tracy ME; Tesic V; Stamenic TT; Joksimovic SM; Busquet N; Jevtovic-Todorovic V; Todorovic SM
    Neuropharmacology; 2018 Jun; 135():343-354. PubMed ID: 29578032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.